nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Pigmentation disorder—Temozolomide—melanoma	0.00523	0.101	CcSEcCtD
Molindone—Extrapyramidal disorder—Temozolomide—melanoma	0.00232	0.0447	CcSEcCtD
Molindone—Amenorrhoea—Temozolomide—melanoma	0.00198	0.0383	CcSEcCtD
Molindone—Weight decreased—Vemurafenib—melanoma	0.00194	0.0374	CcSEcCtD
Molindone—Leukocytosis—Carmustine—melanoma	0.00192	0.0371	CcSEcCtD
Molindone—Gynaecomastia—Carmustine—melanoma	0.00161	0.0312	CcSEcCtD
Molindone—Amenorrhoea—Docetaxel—melanoma	0.00132	0.0255	CcSEcCtD
Molindone—Dysphagia—Dactinomycin—melanoma	0.00121	0.0233	CcSEcCtD
Molindone—Weight decreased—Bleomycin—melanoma	0.00117	0.0227	CcSEcCtD
Molindone—Hypotension—Vemurafenib—melanoma	0.00114	0.022	CcSEcCtD
Molindone—Dysphagia—Carmustine—melanoma	0.00113	0.0219	CcSEcCtD
Molindone—Dysphagia—Temozolomide—melanoma	0.00109	0.0211	CcSEcCtD
Molindone—Constipation—Vemurafenib—melanoma	0.00104	0.0201	CcSEcCtD
Molindone—Weight increased—Temozolomide—melanoma	0.000996	0.0192	CcSEcCtD
Molindone—Weight decreased—Temozolomide—melanoma	0.00099	0.0191	CcSEcCtD
Molindone—Leukopenia—Bleomycin—melanoma	0.000809	0.0156	CcSEcCtD
Molindone—Rash—Vemurafenib—melanoma	0.000768	0.0148	CcSEcCtD
Molindone—Dermatitis—Vemurafenib—melanoma	0.000767	0.0148	CcSEcCtD
Molindone—Leukopenia—Dactinomycin—melanoma	0.000755	0.0146	CcSEcCtD
Molindone—Vision blurred—Carmustine—melanoma	0.000744	0.0144	CcSEcCtD
Molindone—Tremor—Carmustine—melanoma	0.000739	0.0143	CcSEcCtD
Molindone—Dysphagia—Docetaxel—melanoma	0.000728	0.014	CcSEcCtD
Molindone—Agitation—Carmustine—melanoma	0.000725	0.014	CcSEcCtD
Molindone—Nausea—Vemurafenib—melanoma	0.000723	0.014	CcSEcCtD
Molindone—Vision blurred—Temozolomide—melanoma	0.000719	0.0139	CcSEcCtD
Molindone—Tremor—Temozolomide—melanoma	0.000714	0.0138	CcSEcCtD
Molindone—Leukopenia—Carmustine—melanoma	0.000706	0.0136	CcSEcCtD
Molindone—Agitation—Temozolomide—melanoma	0.000701	0.0135	CcSEcCtD
Molindone—Hypotension—Bleomycin—melanoma	0.000689	0.0133	CcSEcCtD
Molindone—Leukopenia—Temozolomide—melanoma	0.000682	0.0132	CcSEcCtD
Molindone—Weight increased—Docetaxel—melanoma	0.000662	0.0128	CcSEcCtD
Molindone—Weight decreased—Docetaxel—melanoma	0.000658	0.0127	CcSEcCtD
Molindone—Dyspnoea—Bleomycin—melanoma	0.000658	0.0127	CcSEcCtD
Molindone—Dry mouth—Temozolomide—melanoma	0.000635	0.0123	CcSEcCtD
Molindone—Tachycardia—Carmustine—melanoma	0.000628	0.0121	CcSEcCtD
Molindone—Hypotension—Carmustine—melanoma	0.000602	0.0116	CcSEcCtD
Molindone—Dyspnoea—Carmustine—melanoma	0.000574	0.0111	CcSEcCtD
Molindone—Somnolence—Carmustine—melanoma	0.000572	0.011	CcSEcCtD
Molindone—Dyspnoea—Temozolomide—melanoma	0.000555	0.0107	CcSEcCtD
Molindone—Somnolence—Temozolomide—melanoma	0.000553	0.0107	CcSEcCtD
Molindone—Constipation—Carmustine—melanoma	0.000551	0.0106	CcSEcCtD
Molindone—Constipation—Temozolomide—melanoma	0.000532	0.0103	CcSEcCtD
Molindone—Muscle spasms—Docetaxel—melanoma	0.000487	0.00941	CcSEcCtD
Molindone—Rash—Bleomycin—melanoma	0.000465	0.00898	CcSEcCtD
Molindone—Dermatitis—Bleomycin—melanoma	0.000465	0.00897	CcSEcCtD
Molindone—Leukopenia—Docetaxel—melanoma	0.000454	0.00876	CcSEcCtD
Molindone—Nausea—Bleomycin—melanoma	0.000438	0.00846	CcSEcCtD
Molindone—HTR2A—hindlimb—melanoma	0.000437	0.121	CbGeAlD
Molindone—Rash—Dactinomycin—melanoma	0.000434	0.00837	CcSEcCtD
Molindone—Dry mouth—Docetaxel—melanoma	0.000422	0.00815	CcSEcCtD
Molindone—Nausea—Dactinomycin—melanoma	0.000409	0.00789	CcSEcCtD
Molindone—Rash—Carmustine—melanoma	0.000406	0.00784	CcSEcCtD
Molindone—Dermatitis—Carmustine—melanoma	0.000406	0.00783	CcSEcCtD
Molindone—Tachycardia—Docetaxel—melanoma	0.000404	0.00779	CcSEcCtD
Molindone—Rash—Temozolomide—melanoma	0.000392	0.00757	CcSEcCtD
Molindone—Dermatitis—Temozolomide—melanoma	0.000392	0.00757	CcSEcCtD
Molindone—Hypotension—Docetaxel—melanoma	0.000387	0.00746	CcSEcCtD
Molindone—Nausea—Carmustine—melanoma	0.000382	0.00738	CcSEcCtD
Molindone—HTR2A—appendage—melanoma	0.000375	0.104	CbGeAlD
Molindone—Nausea—Temozolomide—melanoma	0.00037	0.00713	CcSEcCtD
Molindone—Dyspnoea—Docetaxel—melanoma	0.000369	0.00712	CcSEcCtD
Molindone—Somnolence—Docetaxel—melanoma	0.000368	0.0071	CcSEcCtD
Molindone—HTR7—endothelium—melanoma	0.000363	0.101	CbGeAlD
Molindone—Constipation—Docetaxel—melanoma	0.000354	0.00683	CcSEcCtD
Molindone—HTR7—blood vessel—melanoma	0.000335	0.0929	CbGeAlD
Molindone—Rash—Docetaxel—melanoma	0.000261	0.00504	CcSEcCtD
Molindone—Dermatitis—Docetaxel—melanoma	0.000261	0.00503	CcSEcCtD
Molindone—Nausea—Docetaxel—melanoma	0.000246	0.00474	CcSEcCtD
Molindone—HTR7—neck—melanoma	0.00024	0.0665	CbGeAlD
Molindone—HTR2A—endothelium—melanoma	0.000226	0.0628	CbGeAlD
Molindone—HTR2A—blood vessel—melanoma	0.000209	0.0579	CbGeAlD
Molindone—DRD2—eye—melanoma	0.000169	0.0467	CbGeAlD
Molindone—DRD2—retina—melanoma	0.000167	0.0463	CbGeAlD
Molindone—HTR2A—neck—melanoma	0.000149	0.0414	CbGeAlD
Molindone—CHRM1—head—melanoma	0.000119	0.0329	CbGeAlD
Molindone—HTR2A—eye—melanoma	0.000111	0.0308	CbGeAlD
Molindone—HTR2A—retina—melanoma	0.00011	0.0306	CbGeAlD
Molindone—HTR1A—head—melanoma	0.000106	0.0294	CbGeAlD
Molindone—ADRA2A—mammalian vulva—melanoma	0.000104	0.0288	CbGeAlD
Molindone—HTR7—head—melanoma	0.000101	0.0281	CbGeAlD
Molindone—ADRA2A—Hemostasis—AKT1—melanoma	9.88e-05	0.000105	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NOTCH1—melanoma	9.87e-05	0.000104	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CD80—melanoma	9.83e-05	0.000104	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CD—melanoma	9.82e-05	0.000104	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NOTCH1—melanoma	9.82e-05	0.000104	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—APC—melanoma	9.81e-05	0.000104	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CG—melanoma	9.81e-05	0.000104	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KIT—melanoma	9.81e-05	0.000104	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—NRAS—melanoma	9.81e-05	0.000104	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—melanoma	9.74e-05	0.000103	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—PIK3CA—melanoma	9.73e-05	0.000103	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGF—melanoma	9.7e-05	0.000103	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CD80—melanoma	9.67e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KIT—melanoma	9.65e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CG—melanoma	9.65e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—APC—melanoma	9.65e-05	0.000102	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—NRAS—melanoma	9.65e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CD80—melanoma	9.62e-05	0.000102	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—KRAS—melanoma	9.61e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CG—melanoma	9.6e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—APC—melanoma	9.6e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KIT—melanoma	9.6e-05	0.000102	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—NRAS—melanoma	9.6e-05	0.000102	CbGpPWpGaD
Molindone—DRD2—head—melanoma	9.57e-05	0.0265	CbGeAlD
Molindone—HTR2A—Signaling Pathways—EGF—melanoma	9.54e-05	0.000101	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KDR—melanoma	9.53e-05	0.000101	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGF—melanoma	9.49e-05	0.0001	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—FGF2—melanoma	9.4e-05	9.95e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK3—melanoma	9.39e-05	9.94e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK3—melanoma	9.24e-05	9.78e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CD—melanoma	9.23e-05	9.77e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—BRAF—melanoma	9.22e-05	9.76e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK3—melanoma	9.19e-05	9.73e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FN1—melanoma	9.17e-05	9.71e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—melanoma	9.11e-05	9.65e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—BRAF—melanoma	9.07e-05	9.6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—BRAF—melanoma	9.02e-05	9.55e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VEGFA—melanoma	9.02e-05	9.54e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IGF1—melanoma	8.98e-05	9.51e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NOTCH1—melanoma	8.98e-05	9.51e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—MAPK1—melanoma	8.94e-05	9.46e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—EGFR—melanoma	8.94e-05	9.46e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—STAT3—melanoma	8.93e-05	9.45e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NRAS—melanoma	8.91e-05	9.43e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IGF1—melanoma	8.84e-05	9.35e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PIK3CA—melanoma	8.83e-05	9.35e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MDM2—melanoma	8.8e-05	9.31e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CD80—melanoma	8.8e-05	9.31e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—MAPK1—melanoma	8.79e-05	9.31e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—EGFR—melanoma	8.79e-05	9.31e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IGF1—melanoma	8.79e-05	9.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—APC—melanoma	8.78e-05	9.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CG—melanoma	8.78e-05	9.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KIT—melanoma	8.78e-05	9.3e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—NRAS—melanoma	8.78e-05	9.3e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—MAPK1—melanoma	8.75e-05	9.26e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—EGFR—melanoma	8.75e-05	9.26e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAP2K1—melanoma	8.68e-05	9.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGF—melanoma	8.68e-05	9.19e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ERBB2—melanoma	8.67e-05	9.18e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CD—melanoma	8.62e-05	9.13e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CB—melanoma	8.56e-05	9.06e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—PIK3CA—melanoma	8.54e-05	9.04e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAP2K1—melanoma	8.54e-05	9.04e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK3—melanoma	8.53e-05	9.03e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAP2K1—melanoma	8.49e-05	8.99e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CD—melanoma	8.48e-05	8.98e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KRAS—melanoma	8.44e-05	8.94e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CD—melanoma	8.44e-05	8.93e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK3—melanoma	8.41e-05	8.9e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	8.4e-05	8.9e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	8.36e-05	8.85e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KRAS—melanoma	8.31e-05	8.79e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—melanoma	8.29e-05	8.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KRAS—melanoma	8.26e-05	8.75e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—FGF2—melanoma	8.26e-05	8.74e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—BRAF—melanoma	8.25e-05	8.74e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL8—melanoma	8.23e-05	8.71e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—melanoma	8.17e-05	8.65e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—FGF2—melanoma	8.12e-05	8.6e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MAPK1—melanoma	8.11e-05	8.59e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—EGFR—melanoma	8.11e-05	8.59e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—FGF2—melanoma	8.08e-05	8.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CB—melanoma	8.05e-05	8.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IGF1—melanoma	8.04e-05	8.51e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CDKN1B—melanoma	8.03e-05	8.5e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—MAPK1—melanoma	8e-05	8.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—EGFR—melanoma	8e-05	8.47e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTGS2—melanoma	7.97e-05	8.44e-05	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—melanoma	7.95e-05	8.41e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—melanoma	7.87e-05	8.34e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL2—melanoma	7.86e-05	8.32e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—melanoma	7.82e-05	8.28e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAP2K1—melanoma	7.77e-05	8.23e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PIK3CA—melanoma	7.76e-05	8.21e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MDM2—melanoma	7.72e-05	8.18e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CD—melanoma	7.72e-05	8.17e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KRAS—melanoma	7.66e-05	8.11e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCND1—melanoma	7.66e-05	8.11e-05	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—PIK3CA—melanoma	7.65e-05	8.09e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PIK3CA—melanoma	7.63e-05	8.08e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ERBB2—melanoma	7.62e-05	8.06e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MDM2—melanoma	7.6e-05	8.05e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PIK3CA—melanoma	7.59e-05	8.04e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CTNNB1—melanoma	7.59e-05	8.03e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MDM2—melanoma	7.56e-05	8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KRAS—melanoma	7.56e-05	8e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CB—melanoma	7.52e-05	7.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ERBB2—melanoma	7.49e-05	7.93e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ERBB2—melanoma	7.45e-05	7.89e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MMP9—melanoma	7.44e-05	7.88e-05	CbGpPWpGaD
Molindone—ADRA2A—head—melanoma	7.42e-05	0.0206	CbGeAlD
Molindone—HTR1A—Signaling Pathways—CDKN1A—melanoma	7.41e-05	7.85e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PTEN—melanoma	7.4e-05	7.83e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CB—melanoma	7.39e-05	7.83e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—FGF2—melanoma	7.39e-05	7.82e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NFKB1—melanoma	7.36e-05	7.79e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CB—melanoma	7.36e-05	7.79e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL8—melanoma	7.22e-05	7.65e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—melanoma	7.22e-05	7.64e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—melanoma	7.18e-05	7.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL8—melanoma	7.11e-05	7.52e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL8—melanoma	7.07e-05	7.48e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—melanoma	7.06e-05	7.47e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1B—melanoma	7.05e-05	7.47e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PIK3CA—melanoma	7.04e-05	7.45e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—melanoma	7.02e-05	7.43e-05	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—melanoma	6.98e-05	7.39e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PTEN—melanoma	6.95e-05	7.36e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PIK3CA—melanoma	6.94e-05	7.35e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1B—melanoma	6.94e-05	7.35e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MDM2—melanoma	6.91e-05	7.32e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—melanoma	6.91e-05	7.32e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1B—melanoma	6.9e-05	7.31e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL2—melanoma	6.9e-05	7.31e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—melanoma	6.87e-05	7.27e-05	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—melanoma	6.86e-05	7.27e-05	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—melanoma	6.83e-05	7.23e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ERBB2—melanoma	6.82e-05	7.22e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—melanoma	6.81e-05	7.21e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—melanoma	6.8e-05	7.2e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL2—melanoma	6.79e-05	7.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—melanoma	6.77e-05	7.16e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—melanoma	6.76e-05	7.15e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL2—melanoma	6.76e-05	7.15e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCND1—melanoma	6.73e-05	7.12e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CB—melanoma	6.73e-05	7.12e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—melanoma	6.72e-05	7.12e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VEGFA—melanoma	6.68e-05	7.07e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CTNNB1—melanoma	6.66e-05	7.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCND1—melanoma	6.62e-05	7.01e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—STAT3—melanoma	6.62e-05	7e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NRAS—melanoma	6.6e-05	6.99e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCND1—melanoma	6.59e-05	6.97e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CTNNB1—melanoma	6.56e-05	6.94e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MMP9—melanoma	6.53e-05	6.92e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CTNNB1—melanoma	6.52e-05	6.9e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—melanoma	6.51e-05	6.9e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CDKN1A—melanoma	6.51e-05	6.89e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTEN—melanoma	6.49e-05	6.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL8—melanoma	6.47e-05	6.84e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NFKB1—melanoma	6.46e-05	6.84e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MMP9—melanoma	6.43e-05	6.8e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—melanoma	6.42e-05	6.8e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CDKN1A—melanoma	6.4e-05	6.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MMP9—melanoma	6.39e-05	6.77e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTEN—melanoma	6.39e-05	6.77e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CDKN1A—melanoma	6.37e-05	6.74e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NFKB1—melanoma	6.36e-05	6.73e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTEN—melanoma	6.36e-05	6.73e-05	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—melanoma	6.34e-05	6.71e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NFKB1—melanoma	6.33e-05	6.7e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK3—melanoma	6.32e-05	6.69e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1B—melanoma	6.31e-05	6.68e-05	CbGpPWpGaD
Molindone—HTR2A—head—melanoma	6.31e-05	0.0175	CbGeAlD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—melanoma	6.25e-05	6.61e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—melanoma	6.24e-05	6.6e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—melanoma	6.23e-05	6.6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—melanoma	6.2e-05	6.56e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—melanoma	6.19e-05	6.55e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL2—melanoma	6.18e-05	6.54e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—melanoma	6.15e-05	6.51e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—melanoma	6.15e-05	6.51e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCND1—melanoma	6.02e-05	6.38e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MAPK1—melanoma	6.01e-05	6.37e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—EGFR—melanoma	6.01e-05	6.37e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CTNNB1—melanoma	5.96e-05	6.31e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VEGFA—melanoma	5.87e-05	6.21e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MMP9—melanoma	5.85e-05	6.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CDKN1A—melanoma	5.83e-05	6.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTEN—melanoma	5.81e-05	6.15e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—STAT3—melanoma	5.81e-05	6.15e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NRAS—melanoma	5.79e-05	6.13e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NFKB1—melanoma	5.79e-05	6.13e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VEGFA—melanoma	5.77e-05	6.11e-05	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—melanoma	5.75e-05	6.09e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VEGFA—melanoma	5.74e-05	6.08e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—STAT3—melanoma	5.71e-05	6.05e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NRAS—melanoma	5.7e-05	6.04e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—STAT3—melanoma	5.68e-05	6.02e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KRAS—melanoma	5.68e-05	6.01e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—melanoma	5.67e-05	6e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NRAS—melanoma	5.67e-05	6e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK3—melanoma	5.55e-05	5.87e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MAPK3—melanoma	5.46e-05	5.78e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK3—melanoma	5.43e-05	5.75e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—melanoma	5.4e-05	5.71e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—melanoma	5.31e-05	5.62e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—melanoma	5.28e-05	5.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MAPK1—melanoma	5.28e-05	5.59e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—EGFR—melanoma	5.28e-05	5.59e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VEGFA—melanoma	5.25e-05	5.56e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PIK3CA—melanoma	5.22e-05	5.52e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—STAT3—melanoma	5.2e-05	5.5e-05	CbGpPWpGaD
Molindone—ADRA2A—lymph node—melanoma	5.2e-05	0.0144	CbGeAlD
Molindone—HTR2A—Signaling Pathways—MAPK1—melanoma	5.2e-05	5.5e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—EGFR—melanoma	5.19e-05	5.5e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NRAS—melanoma	5.19e-05	5.49e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MAPK1—melanoma	5.17e-05	5.47e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—EGFR—melanoma	5.17e-05	5.47e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—melanoma	5.05e-05	5.34e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KRAS—melanoma	4.99e-05	5.28e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK3—melanoma	4.97e-05	5.26e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KRAS—melanoma	4.91e-05	5.19e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PIK3CA—melanoma	4.9e-05	5.19e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KRAS—melanoma	4.88e-05	5.17e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—melanoma	4.83e-05	5.11e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—melanoma	4.83e-05	5.11e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MAPK1—melanoma	4.73e-05	5e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—EGFR—melanoma	4.73e-05	5e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—melanoma	4.62e-05	4.89e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PIK3CA—melanoma	4.58e-05	4.85e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PIK3CA—melanoma	4.51e-05	4.77e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PIK3CA—melanoma	4.48e-05	4.75e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KRAS—melanoma	4.46e-05	4.73e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—melanoma	4.43e-05	4.69e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—melanoma	4.36e-05	4.62e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—melanoma	4.34e-05	4.59e-05	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—melanoma	4.26e-05	4.51e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—melanoma	4.24e-05	4.49e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—melanoma	4.17e-05	4.42e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—melanoma	4.15e-05	4.39e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PIK3CA—melanoma	4.1e-05	4.34e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—melanoma	4.06e-05	4.29e-05	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—melanoma	4.01e-05	4.24e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—melanoma	3.99e-05	4.23e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—melanoma	3.97e-05	4.2e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—melanoma	3.97e-05	4.2e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—melanoma	3.79e-05	4.02e-05	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—melanoma	3.74e-05	3.96e-05	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—melanoma	3.68e-05	3.9e-05	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—melanoma	3.66e-05	3.88e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—melanoma	3.63e-05	3.84e-05	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—melanoma	3.35e-05	3.55e-05	CbGpPWpGaD
